Letter to Secretary Burwell Re: Long-Term Care Pharmacy
The Senior Care Pharmacy Coalition (“SCPC”), on behalf of the long term care (“LTC”) pharmacies it represents and the residents of LTC facilities whom those pharmacies serve, is writing to ask your help in reconciling a conflict between two of the agencies within your Department – the Food and Drug Administration (“FDA”) and the Center for Medicare and Medicaid Services (“CMS”) – related to packaging of prescription drugs in long term care (“LTC”) pharmacies. The CMS Requirements of Participation for nursing homes require LTC pharmacies to dispense medications to residents in specialized packaging and provide emergency medications that must be kept on-site at the facility (known as “e-kits”). However a draft FDA guidance issued in 2015 entitled “Draft Guidance for Industry: Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities” (Feb. 2015) (the “Draft Guidance”) would, if finalized, prohibit LTC pharmacies for preparing the very same packaging and providing e-kits for residents of LTC facilities that the Requirements of Participation demand. The vast majority of medications dispensed for these patients are not available from manufacturers, wholesalers or licensed repackagers in the appropriate specialized packaging. Given that LTC pharmacies have for decades been safely packaging these medications in compliance with CMS and pharmacy requirements, we seek your assistance to avoid the emerging conflict.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.